The insurer said in a Wednesday news release it is also committed to helping its affiliated health plans double the number of consumers who receive counseling as part of medication-assisted therapy for opioid addiction.
The insurer said internal research found that of its policyholders who received buprenorphine — a medication designed to curb opioid addiction — only 16 percent to 19 percent of members participated in recommended in-person counseling.
“Making improvements with coordination and integration of medical and behavioral healthcare is an important factor to consider in efforts to mitigate these medical risks,” Craig Samitt, MD, Anthem chief clinical officer, said in the release. “Health insurers can and should play a strong role in making changes to improve the lives of their members.”
Anthem said the aggressive goals are the product of Anthem medical directors, nurses, pharmacists, care managers and benefits experts reexamining policies over the last year.
More articles on payer issues:
CMS finds 45% of Medicare Advantage provider directories need updates
Anthem extends deadline for Cigna deal
Medica CEO retires: 5 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
